Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-023724
Filing Date
2024-09-19
Accepted
2024-09-19 18:31:10
Documents
1
Period of Report
2024-09-17

Document Format Files

Seq Description Document Type Size
1 form4-09192024_100906.html 4  
1 form4-09192024_100906.xml 4 4312
  Complete submission text file 0001415889-24-023724.txt   5878
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Issuer) CIK: 0001419041 (see all company filings)

EIN.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FORTE BIOSCINCES, INC. 3060 PEGASUS PARK DR., BLDG 6 DALLAS TX 75247
Business Address
Kapoor Shivpreet Singh (Reporting) CIK: 0002038311 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38052 | Film No.: 241311404